Cytotoxic T Lymphocyte Therapy for Epstein-Barr Virus(+) Hodgkin's Disease

Epstein Barr virus (EBV)(+) Hodgkin's disease (HD) expresses clearly identified tumor antigens derived from the virus and could, in principle, be a target for adoptive immunotherapy with viral antigen–specific T cells. However, like most tumor-associated antigens in immunocompetent hosts, these...

Descripción completa

Detalles Bibliográficos
Autores principales: Bollard, Catherine M., Aguilar, Laura, Straathof, Karin C., Gahn, Benedikt, Huls, M. Helen, Rousseau, Alexandra, Sixbey, John, Gresik, M. Victoria, Carrum, George, Hudson, Melissa, Dilloo, Dagmar, Gee, Adrian, Brenner, Malcolm K., Rooney, Cliona M., Heslop, Helen E.
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2004
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2211993/
https://www.ncbi.nlm.nih.gov/pubmed/15611290
http://dx.doi.org/10.1084/jem.20040890

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2211993/
https://www.ncbi.nlm.nih.gov/pubmed/15611290
http://dx.doi.org/10.1084/jem.20040890

Ejemplares similares